Advances in research on Rotavin-M1

Authors

  • Thi Luan Le Center for the Research and Production of Vaccines and Biologicals
  • Van Man Nguyen Center for the Research and Production of Vaccines and Biologicals
  • Thuy Huong Nguyen Center for the Research and Production of Vaccines and Biologicals
  • Duc Anh Dang National Institute of Hygiene and Epidemiology
  • Van Trang Nguyen National Institute of Hygiene and Epidemiology
  • Bich Hanh Tran Center for the Research and Production of Vaccines and Biologicals
  • Thi Giang Huong Tran Ministry of Health
  • Thi Oanh Tran Ministry of Health
  • Gia Khanh Pham Ministry of Science and Technology
  • Baoming Jiang Center for Disease Control and Prevention (CDC), USA
  • Roger Glass National Institute of Health (NIH), USA
  • Duncan Steel PATH, USA
  • Dang Hien Nguyen* Center for the Research and Production of Vaccines and Biologicals

Abstract

“Rotavin-M1” is an oral live-attenuated vaccine that prevents diarrhea in children under five years old, produced from rotavirus strains G1P [1] on Vero cells. This vaccine has been studied for 16 years beginning with monitoring the local circulating strain and eventually establishing a seed lots system. The safety and immunogenicity of the vaccine were found equivalent to internationallyimported vaccines.

Keywords:

G1P, Rotavin-M1, vaccine

DOI:

https://doi.org/10.31276/VJSTE.59(1).43

Classification number

3.2

Downloads

Published

2017-03-15

Received 23 December 2016; accepted 24 February 2017

How to Cite

Thi Luan Le, Van Man Nguyen, Thuy Huong Nguyen, Duc Anh Dang, Van Trang Nguyen, Bich Hanh Tran, Thi Giang Huong Tran, Thi Oanh Tran, Gia Khanh Pham, Baoming Jiang, Roger Glass, Duncan Steel, & Dang Hien Nguyen. (2017). Advances in research on Rotavin-M1. Vietnam Journal of Science, Technology and Engineering, 59(1), 43-48. https://doi.org/10.31276/VJSTE.59(1).43

Issue

Section

Life Sciences